Advertisement
Soligenix Says FDA Grants Type A Meeting Regarding New Drug Application For HyBryte
(RTTNews) - Biopharmaceutical company Soligenix, Inc. (SNGX) announced Monday that the U.S. Food and Drug Administration (FDA) has granted a Type A meeting to discuss the contents of a refusal to file (RTF) letter previously issued regarding the Company's new drug application (NDA) for HyBryte (synthetic hypericin) in the treatment of early stage cutaneous T-cell lymphoma (CTCL), a rare cancer.
The company has successfully demonstrated statistically significant results in a Phase 3 clinical trial.
The company said it intends to provide a further update once it receives the minutes from the meeting or when it has more clarity on next steps, which is anticipated by or before the end of April.
For More Such Health News, visit rttnews.com
read more
U.S. Dollar Falls Against Most Majors
The U.S. dollar weakened against its most major counterparts in the New York session on Friday.
RTTNews
|
51 minutes ago
German Inflation Accelerates To 2.2% In August
Consumer price inflation in Germany climbed in August to its highest level in five months, while the core figure was steady amid an acceleration in food price growth, and weakened chances for further easing from the European Central Bank in the near term.
RTTNews
|
2h 10min ago
Canadian Market Up In Positive Territory; BRP Rises Sharply On Strong Earnings
Despite weak GDP data, the Canadian market is up firmly in positive territory Friday afternoon with stocks from materials and healthcare sectors contributing significantly to the gains.
RTTNews
|
4h 24min ago
Swiss Market Ends Modestly Lower
Save for a very brief while early on in the session, and for less than an hour a little past mid afternoon, the Switzerland market stayed in negative territory on Friday with investors largely staying cautious due to a lack of positive triggers.
RTTNews
|
5h 0min ago
European Stocks Close Lower On Geopolitical Tensions
European stocks closed lower on Friday, weighed down by geopolitical concerns due to rising clashes in Gaza and Ukraine, and political uncertainty in France. Investors also digested the latest batch of economic data, including the closely watched U.S. personal consumption expenditure report.
RTTNews
|
5h 29min ago
U.S. Consumer Sentiment Deteriorates Slightly More Than Initially Estimated In August
The University of Michigan released a report on Friday showing consumer sentiment in the U.S. deteriorated by slightly more than previously estimated in the month of August. The report said the consumer sentiment index for August was downwardly revised to 58.2 from the preliminary reading of 58.6.
RTTNews
|
8h 13min ago
Chicago Business Barometer Slumps Much More Than Expected In August
MNI Indicators released a report on Friday showing a sharp pullback by its reading on Chicago-area business activity in the month of August. The report said the Chicago business barometer tumbled to 41.5 in August after jumping to 47.1 in July, with a reading below 50 indicating contraction. Economists had expected the business barometer to edge down to 46.0.
RTTNews
|
8h 32min ago
U.S. Consumer Prices Increase In Line With Estimates In July
Consumer prices in the U.S. increased in line with economist estimates in the month of July, according to closely watched data released by the Commerce Department on Friday. The Commerce Department said its personal consumption expenditures (PCE) price index rose by 0.2 percent in July after climbing 0.3 percent in June. The uptick matched expectations.
RTTNews
|
9h 15min ago
